Sulindac 25 g | ≥98% LKT Laboratories, Inc. NSAID; COX-1/2 and PDE inhibitor. More Information Supplier Page × Sulindac
Sulindac Sulfone 500 mg | ≥98% LKT Laboratories, Inc. NSAID; COX-1/2 and PDE inhibitor. More Information Supplier Page × Sulindac Sulfone
Sulbactam 5 g | ≥98% LKT Laboratories, Inc. β-lactamase inhibitor. More Information Supplier Page × Sulbactam
Sulbactam 1 g | ≥98% LKT Laboratories, Inc. β-lactamase inhibitor. More Information Supplier Page × Sulbactam
R-Sulforaphane 50 mg | ≥98% LKT Laboratories, Inc. ITC found in cruciferous vegetables; AhR antagonist. More Information Supplier Page × R-Sulforaphane
Mebendazole 5 g | ≥98% LKT Laboratories, Inc. Benzimidazole; microtubule polymerization inhibitor. More Information Supplier Page × Mebendazole
Mefenamic Acid 100 g | ≥98% LKT Laboratories, Inc. NSAID; GABA-A potentiator, COX-1/2 inhibitor. More Information Supplier Page × Mefenamic Acid
Mefenamic Acid 50 g | ≥98% LKT Laboratories, Inc. NSAID; GABA-A potentiator, COX-1/2 inhibitor. More Information Supplier Page × Mefenamic Acid
Mefenamic Acid 10 g | ≥98% LKT Laboratories, Inc. NSAID; GABA-A potentiator, COX-1/2 inhibitor. More Information Supplier Page × Mefenamic Acid
Strontium Ranelate 5 g | ≥98% LKT Laboratories, Inc. Bone deterioration inhibitor, potential CaR agonist. More Information Supplier Page × Strontium Ranelate
